7Baggers
 Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)  Defense World Thu, 02 Oct 2025 06:42:11 GMT
 published on: 2025-09-20 13:45:53  newser.com Sat, 20 Sep 2025 18:45:53 GMT
 forte biosciences launches public offering  MSN Wed, 17 Sep 2025 22:30:29 GMT
 published on: 2025-09-14 17:18:56  newser.com Sun, 14 Sep 2025 22:18:56 GMT
 published on: 2025-09-14 09:32:31  newser.com Sun, 14 Sep 2025 14:32:31 GMT
 published on: 2025-09-14 03:33:18  newser.com Sun, 14 Sep 2025 08:33:18 GMT
 published on: 2025-09-03 22:30:02  Newser Thu, 04 Sep 2025 03:30:02 GMT

Forte Biosciences, Inc.
(NASDAQ:FBRX) 

FBRX stock logo

Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in...

Sector: Healthcare
Industry: Biotechnology

Share this website to your friends